Stanford Medicine magazine reports on why a healthy childhood matters
The fall issue traces the lasting repercussions of early trauma and disease. Also included is an interview with former President Jimmy Carter on global discrimination against women and girls.
Enzyme malfunction may be why binge drinking can lead to alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Drug disarms deadly C. difficile bacteria without destroying healthy gut flora
A drug that blocks the intestinal pathogen without killing resident, beneficial microbes may prove superior to antibiotics, currently the front-line treatment for the infection.
Combination drug therapy shrinks pancreatic tumors in mice
When used together, two drugs that affect the structure and function of DNA blocked the growth of pancreatic tumor cells in mice. Researchers hope the drugs can soon be tested in humans with pancreatic cancer.
Filtered sunlight a safe, low-tech treatment for newborn jaundice
Safe sunlight exposure under canopies that remove harmful rays is a low-cost, effective way to give phototherapy to jaundiced infants in impoverished settings, according to a new study.
Delivering missing protein heals damaged hearts in animals, Stanford-led study finds
Researchers have discovered that a particular protein, Fstl1, plays a key role in regenerating dead heart-muscle cells.
5 Questions: Euan Ashley on diagnosing the undiagnosable
A national program to diagnose difficult-to-diagnose patients is taking root at Stanford under the guidance of heart specialist Euan Ashley.
Large-scale treatment of parasitic-worm disease cost-effective, Stanford-led study shows
Researchers are urging WHO to recommend broader and more frequent treatment of parasitic-worm diseases, which affect 1.5 billion people worldwide.
Drug prevents Type 1 diabetes in mice
A compound that blocks the synthesis of hyaluronan, a substance generally found in in all body tissue, protected mice from getting Type 1 diabetes. The compound is already approved in Europe and Asia for the treatment of gallbladder disease.
Carlos Bustamante named chair of new Department of Biomedical Data Science
Population geneticist Carlos Bustamante will lead a new biomedical data department founded to advance precision health.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.